BioSpace Collaborative

Academic/Biomedical Research
News & Jobs
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login          Employers:  Register | Login  

NEWSLETTERS
Free Newsletters
Archive
My Subscriptions

NEWS
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE

CAREER NETWORK
Job Seeker Login
Most Recent Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

HOTBEDS
Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Genetown
  Pharm Country
  BioCapital
  BioMidwest
  Bio NC
  BioForest
  Southern Pharm
  BioCanada East
  US Device
Europe
Asia

DIVERSITY

PROFILES
Company Profiles

INTELLIGENCE
Research Store

INDUSTRY EVENTS
Research Events
Post an Event
RESOURCES
Real Estate
Business Opportunities

 News | News By Subject | News by Disease News By Date | Search News
Get Our Industry eNewsletter FREE email:    
   

GEA Pharma Systems's VAPOVAC(TM): H2O2 Sterilisation for Pharmaceutical Freeze Dryers, Gets FDA Approval


3/11/2011 9:59:14 AM

VAPOVAC™ the latest technology for H2O2 gas sterilisation of pharmaceutical freeze dryers from GEA Lyophil, has recently achieved approval from the US Food and Drugs Administration (FDA). FDA approval has now cleared the way for GEA Lyophil to market the system worldwide. The system is ideally suited to pharmaceutical applications that require sterile conditions without the stresses and high power usage associated with steam sterilisation techniques.

With VAPOVAC™, GEA Lyophil has developed a less expensive option using H2O2

(Hydrogen Peroxide) that is faster, safer, more efficient and easier on the environment than steam. The technology is available both for new plants and as a retrofit for existing installations.

The VAPOVAC™ steriliser uses hydrogen peroxide to sterilise equipment under vacuum in a three-stage process: drying, sterilisation and aeration. Only a very small quantity of hydrogen peroxide is used to penetrate the freeze dryer vessels and all associated piping of the equipment. This method effectively eliminates all residual contamination. The freeze dryer is then fully vented, leaving no harmful residues.

GEA Lyophil is the only company to offer this technology. Hubert Kluetsch, Director of Sales and Marketing for the company said that the FDA approval was very important. “Not having the FDA approval has held us back until now as so many potential customers were unable to consider technology that did not have the FDA stamp,” he said. “Now that the FDA has given VAPOVAC™ its seal of approval, many new markets will be open for us.”

VAPOVAC™ is just one of the freeze drying products supplied by GEA Lyophil for the pharmaceutical industry. The full range include: laboratory freeze dryers, both pilot scale for R&D and small production batches; industrial freeze dryers; and complete freeze dryer systems with Automatic Loading and Unloading Systems (ALUS®), integrated isolators, and CIP/SIP skids.

For further editorial information contact:

Steve Jordan - The Words Workshop Ltd. 26 Swanwick Lane, Milton Keynes, MK10 9LD, England. Tel: (44) (0) 1908 695500 Fax: (44) (0) 1908 690099 E-mail: steve@thewordsworkshop.co.uk Web: www.thewordsworkshop.co.uk

For further business information contact:

Hubert Kluetsch - Director Sales and Marketing GEA Lyophil GmbH Kalscheurener Str. 92 50354 Huerth Germany Tel: +49 (0) 2233/6999-220 Fax: +49 (0) 2233/6999-8220 E-mail: lyophil@geagroup.com www.geapharmasystems.com

Since the VAPOVAC technology fulfils all conditions for the sterilisation of machines in pharmaceutical industry, the acknowledgment took place via the FDA. It is guaranteed that the process can be validated and leads to the appropriate sterilisation result (SAL=10 exp.6).



Read at BioSpace.com

   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES
 

//-->